Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Britain has no plans to halt rapid COVID-19 testing - health ministry

Published 15/04/2021, 21:19
Updated 16/04/2021, 03:01
© Reuters. People queue outside a test centre in Southend-on-sea

By Kanishka Singh

(Reuters) - Britain's health ministry said on Thursday there were no plans to halt rapid coronavirus testing, after the Guardian newspaper reported the programme may be scaled back in England because of concerns about false positives.

"With around one in three people not showing symptoms of COVID-19, regular, rapid testing is an essential tool to control the spread of the virus as restrictions ease by picking up cases that would not otherwise have been detected," a ministry spokeswoman said in an emailed statement.

"Rapid testing detects cases quickly, meaning positive cases can isolate immediately, and figures show that for every 1,000 lateral flow tests carried out, there is fewer than one false positive result."

Citing leaked emails, the Guardian reported on Thursday that senior officials were considering scaling back the widespread testing of people without symptoms, due to worries about a growing number of false positives in places where COVID-19 rates are low, such as London.

The spokeswoman said regional models were based on too small a sample size to draw conclusions, adding "there are no plans to halt the universal programme".

Britain reported 2,672 new COVID-19 cases on Thursday, government data showed, up slightly from 2,491 on Wednesday but taking the fall over the last seven days to almost 7% compared with a week earlier.

© Reuters. Surge testing for the coronavirus disease (COVID-19) in the Barnet area of London

A total of 32.44 million people had received a first dose of a vaccine against coronavirus by April 14 and 8.51 million people had received a second dose.

Latest comments

forget the lefty Guardian
absolutely no reliable evidence that asymptomatic transmission drives infection
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.